Futu Information on December 9 | the three major indexes rose collectively, with the Hang Seng Index up 2.32%, the Hang Seng Index up 2.33%, and the National Index up 2.51%.

As of the close, Hong Kong stocks rose 1378, fell 627, and closed flat at 948.

The specific industry performance is shown below:

Plate aspectMost of the science and Internet stocks rose.Meituan, BABA, Baidu, Inc., Tencent and JD.com rose nearly 6%, 3%, 5%, 2% and 1% respectively.

Real estate and property management stocks pull up hand in handLongfor Group rose by more than 18%, Xuhui Holdings by nearly 14%, Country Garden Services Holdings by nearly 10%, and Xuhui Yongsheng service by more than 14%.

Building materials stocks have risen significantly.Anhui Conch Cement rose by more than 6%, China Resources cement and China National Building Material by more than 7%.

Apple Inc's concept stock rose.Sunny Optical Technology rose by more than 6%, BYD Electronic by nearly 4%, and Qiu Ti Technology rose.

Non-ferrous metal stocks were pulled up after noon.Zijin Mining Group rose by more than 5%, China Molybdenum by nearly 7% and Ganfeng Lithium by more than 2%.

Individual stocks$CIFI HOLD GP (00884.HK)$It rose nearly 14%, and many departments in Shanghai expressed support for the reasonable growth of real estate financing.

$SHENZHOU INTL (02313.HK)$Up more than 9%, the agency expects Q4 as the bottom of the performance, and sales will return to positive growth from the second quarter of next year.

$SANDS CHINA LTD (01928.HK)$It rose by nearly 2%, and Macao cancelled the arrival inspection of people entering the country.

$SUNNY OPTICAL (02382.HK)$A rise of more than 6% led the mobile phone industry chain, and the agency said consumer electronics demand is expected to gradually recover in the future.

$SCICLONE PHARMA (06600.HK)$With a rise of more than 12%, nacitumab injection was approved to be put on the market for the treatment of neuroblastoma.

Today's turnover of Hong Kong shares TOP20

Institutional viewpoint

• Xiao Mo: there may still be room for upward valuation of gaming stocks, and Sands China Ltd. is the first choice for the industry.

Xiaomo released a research report saying that it is still optimistic about the Macau gaming sector, is satisfied with the current valuation, and believes that the possibility of normalizing EBITDA is on the rise. The bank stressed that although the sector's share price has risen 1.25 times in the past five weeks, its earnings forecasts and valuations still have good room to rise. The bank said it would maintain$SANDS CHINA LTD (01928.HK)$It is the first choice for the industry, considering that its assets and business are at the top of the industry and the valuation is attractive.

• Macquarie: the state-owned enterprise bank may be reevaluated next year, Bank of China Ltd. is the first choice.

Gree released a research report saying that mainland bank stocks are the first choice.$BANK OF CHINA (03988.HK)$Mainly because of its huge exposure to overseas markets The bank said that even if existing mortgages on the mainland may be at risk in the first quarter of next year, SOE banks are expected to be revalued because institutional investors who value earnings and social responsibility may increase their positions. Instead, the bank maintains a cautious view of mixed-ownership banks, arguing that the industry's adjusted return on equity will fall from 10.2 per cent this year to 9.6 per cent next year and rebound to 10.9 per cent in 2024.

• Daiwa: give Baidu a "buy" rating, with the target price rising to HK $195

Daiwa released a research report saying that$BIDU-SW (09888.HK)$The "Buy" rating, which raised its revenue forecast for 2023-24 by 1 per cent, raised its target price from HK $190 to HK $195, making it bullish on core profitability. The bank expects the company's online marketing to recover ahead of schedule, and management aims to break even with its smart cloud services within two to three years. Daiwa also predicts that Baidu, Inc. 's autopilot is expected to start generating revenue and profits by the end of 2023.

• Credit Suisse: downgrade Great Wall Motor to "neutral" and raise the target price to HK $11

Credit Suisse released a research report that will$GREATWALL MOTOR (02333.HK)$The rating was downgraded from "outperform" to "neutral". Due to the reduction in subsidies for potential car buyers, demand in the first quarter of next year will be pushed forward to December this year. The wholesale volume in December is expected to increase by 39% to 122000 vehicles month-on-month, and the target price will be raised from HK $10 to HK $11. There is no potential room for increase. The company's wholesale volume fell 29 per cent in November from a year earlier and 13 per cent month-on-month to more than 87000 vehicles, worse than the 6 per cent year-on-year decline in overall passenger car sales and 8 per cent month-on-month decline, due to the impact of the epidemic on car production, logistics and potential car buyers visiting dealers.

• Morgan Stanley: give Kang Bio-B "overweight" rating, with the target price rising to HK $50

According to a research report released by Morgan Stanley,$AKESO, INC. - B (09926.HK)$The "overweight" rating was raised from HK $30 to HK $50. The company recently entered into a cooperation and licensing agreement with Summit (SMMT.US). Under the agreement, Summit will be granted exclusive licenses to develop and commercialize its breakthrough bispecific antibody PD-1/VEGF,AK112 in the United States, Canada, Europe and Japan, the report said. In exchange, the company receives a down payment of $500 million and a total transaction value of up to $5 billion. The bank sees the deal as the largest in the history of China's health industry as a significant test of the potential of AK112, while the $500m advance significantly strengthens the group's cash position and accelerates other pipeline development and early research and development.

For more popular sections, please see "Futu Niuniu app- Market-Thermal Map":